Riga – Italy is at the forefront of international research against influenza and Ebola: this is the important fact that emerged during “The Fifth ESWI Influenza Conference,” which ends tomorrow in Riga, Latvia. Susanna Esposito is coordinator of the Vaccines Group at the European Society for Clinical Microbiology and Infectious Diseases, and President of the World Association for Infectious Diseases and Immunological Disorders. She attended the conference and explained the progress made so far on the European guidelines for vaccination of adults and the elderly. In terms of Ebola research, continued explaining Esposito, “as announced a few days ago, the biopharmaceutical company Okairos, which has laboratories in Naples and Rome, has identified a new technology to develop vaccines employing adenovirus derived from chimpanzees.” (9Colonne)
